Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 2,617,619 |
|
|||||
| News | (1) | ||||||
| Day High | 5.67 | Low High |
|||||
| Day Low | 5.21 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Editas Medicine Inc | EDIT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.33 | 6.33% | 5.54 | 18:56:42 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.21 | 5.21 | 5.67 | 5.47 | 5.21 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 18,076 | 2,617,619 | US$ 5.40 | US$ 14,136,082 | - | 5.11 - 11.91 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:43:16 | formt | 100 | US$ 5.54 | USD |
Editas Medicine (EDIT) Options Flow Summary
Editas Medicine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 445.89M | 81.81M | - | 78.12M | -153.22M | -1.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Editas Medicine News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDIT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.51 | 5.67 | 5.11 | 5.29 | 1,505,760 | 0.03 | 0.54% |
| 1 Month | 6.82 | 7.09 | 5.11 | 5.98 | 1,665,793 | -1.28 | -18.77% |
| 3 Months | 7.16 | 11.58 | 5.11 | 7.78 | 1,955,908 | -1.62 | -22.63% |
| 6 Months | 6.69 | 11.69 | 5.11 | 8.64 | 1,903,645 | -1.15 | -17.19% |
| 1 Year | 8.08 | 11.91 | 5.11 | 8.63 | 1,843,669 | -2.54 | -31.44% |
| 3 Years | 37.80 | 73.025 | 5.11 | 18.13 | 1,760,708 | -32.26 | -85.34% |
| 5 Years | 25.00 | 99.95 | 5.11 | 25.29 | 1,530,522 | -19.46 | -77.84% |
Editas Medicine Description
| Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. |
